Genticel announces positive preclinical proof of concept results for its multivalent HPV therapeutic vaccine GTL002
2 June 2015 | By
Genticel has announced positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate...